Blaze Bioscience Scores $8.5M
Blaze Bioscience Inc., a developer of products to improve the lives of cancer patients, has raised an $8.5 million Series A round. The round was raised from individual investors, the company said. Blaze is based in Seattle.
22 February 2013•3 mins read
